| Identification | Back Directory | [Name]
7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine | [CAS]
2389988-34-3 | [Synonyms]
TLR7agonist10 7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(b-D-xylofuranosyl)guanine 7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine | [Molecular Formula]
C14H19N5O6 | [MOL File]
2389988-34-3.mol | [Molecular Weight]
353.34 |
| Hazard Information | Back Directory | [Uses]
TLR7 agonist 10 is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|